Adequate bone marrow reserve as evidenced by:
Bone marrow reserve which, in the clinical judgment of the Principal Investigator, is not adequate for participation in this trial.
Patients must have adequate bone marrow reserve as evidenced by:
Poor bone marrow reserve.
Adequate bone marrow reserve
Adequate organ function within  days of study registration including:\r\n* Adequate bone marrow reserve: absolute neutrophil (segmented and bands) count (ANC) >= . x ^/L
Adequate bone marrow reserve as demonstrated by :
Adequate organ function and bone marrow reserve as indicated by the following laboratory assessments performed at screening.
Patients must have adequate bone marrow reserve as evidenced by:
Adequate bone marrow reserve and organ function as demonstrated by complete blood count, and biochemistry in blood and urine at baseline
Poor bone marrow reserve.
And patients must have evidence of adequate bone marrow reserve as shown by platelet count of at least ,/mm^; however, if the cytopenias are due to extensive bone marrow involvement by CLL, patients may be included in the study
Adequate bone marrow reserve (neutrophils > /mm and platelets > / mm)
Adequate bone marrow reserve without transfusions defined as:
Poor bone marrow reserve.
Have adequate organ reserve as determined by laboratory test results obtained within  weeks prior to Study Day  as indicated below:
Adequate bone marrow reserve as evidenced by ANC > .x^/L;Platelet > x^/L
Adequate bone marrow reserve
Has adequate bone marrow reserve as evidenced by:
Subject must have adequate hematologic reserve
Patient with glioblastoma must have adequate bone marrow and immune reserve, as documented by:
Adequate bone marrow reserve: ANC ?/mm, platelets ?,/mm
Have adequate bone marrow reserve and organ function at screening as follows:
Adequate bone marrow reserve as demonstrated by
The patient has adequate bone marrow reserve:  Absolute neutrophil count (ANC) > .  ^/L
Patients must have adequate physiologic reserve as evidenced by:
Patient has adequate bone marrow reserve, as evidenced by:
Adequate bone marrow reserve as defined per protocol;
Have adequate bone marrow reserve defined as:
Patients who have undergone prior stem cell transplant will not be excluded from study entry as long as adequate marrow reserve is demonstrated (refer to hematologic parameters)
Adequate bone marrow reserve
Adequate hepatic reserve